Status:

ACTIVE_NOT_RECRUITING

A Trial on Contraceptive Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles

Lead Sponsor:

Chemo Research

Conditions:

Contraception

Eligibility:

FEMALE

15-45 years

Phase:

PHASE3

Brief Summary

Multicentre, single arm phase III trial to assess the pearl index of LVDS. The trial lasts 13 cycles.The assessments include (but are not limited to) recording demographic data, pregnancy tests, gynae...

Eligibility Criteria

Inclusion

  • At Visit 1a, subjects must meet ALL of the following criteria:
  • Sexually active, postmenarcheal and premenopausal female subjects at risk of pregnancy including breastfeeding women.
  • Women who either
  • have never used hormonal contraceptives before consent/assent (naïve users), or
  • have used hormonal contraceptives in the past, but have had a hormonal contraceptive-free period before consent/assent and a full menstrual cycle during the drug-free period (previous users) or
  • directly switch from another hormonal contraceptive (switchers).
  • Only for subjects who were not pregnant and did not use hormonal contraception during the last 6 months before consent/assent:
  • Regular cycles (i.e. cycle length between 24 and 35 days) during the last 6 months.

Exclusion

  • Pregnancy or wish of pregnancy.
  • Subject is known to or suspected of not being able to comply with the trial protocol, the use of the trial medication or the use of the trial diary.
  • History of infertility.
  • Known bleeding disorder or history of unexplained bleeding or bruising within the last 12 months prior to V1a.
  • Unexplained amenorrhoea.
  • Abnormal finding on pelvic, breast or ultrasound examination that in the investigator's opinion contraindicates participation in the trial.

Key Trial Info

Start Date :

August 9 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 30 2026

Estimated Enrollment :

750 Patients enrolled

Trial Details

Trial ID

NCT06019533

Start Date

August 9 2023

End Date

April 30 2026

Last Update

February 21 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

LR-301/

Móstoles, Madrid, Spain, 28938